22:22 IST
BSE
Other Announcement
Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals informs shareholders that the Annual Report for FY 2025-26 and the 32nd AGM notice are available on the Company's website.
Novelix Pharmaceuticals Ltd
- Share price
- ₹71.95
- Market cap
- ₹126.7 Cr
- Revenue (annual)
- ₹132.3 Cr
- Net profit (annual)
- ₹2.56 Cr
- P/E (TTM)
- 34.9×Sector 66.8×
- Promoter holding
- 54.29%+4.86% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Capital Structure Change 6Other Announcement 4Annual General Meeting 4Fund Raise 3Financial Results 3Board Meeting Date 3Promoter Buying 1Partnership 1Management Change 1Debt & Borrowing 1Capacity Expansion 1Board Meeting Outcome 1Annual Report 1
Time
4 announcements with these filters
18:49 IST
BSE
Other Announcement
Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals filed its Statement of Deviation and Variation for the quarter ended June 30, 2026, reporting no deviations in fund utilization.
17:53 IST
BSE
Other Announcement
Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals declared non-applicability of the Annual Secretarial Compliance Report for FY2026. The company remains exempt due to being below SEBI LODR regulatory thresholds.
19:50 IST
BSE
Other Announcement
Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals Limited has announced its official website address as https://novelixpharma.com in compliance with SEBI Listing Regulations. The website contains all information required under Regulation 46 of the SEBI LODR Regulations, 2015.